Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025


ADC assay now available through ABS; customer study proves IO60 is a spatial workhorse ADC assay now available through ABS; customer study proves IO60 is a spatial workhorse

Continue reading here:
Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

Related Posts